Phio Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Deming David H
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | SCHEDULE 13G/A: Others
Phio Pharmaceuticals | 424B3: Prospectus
Phio Pharmaceuticals | EFFECT: Others
Phio Pharmaceuticals | D: Filing D
Phio Pharmaceuticals | D: Filing D
Phio Pharmaceuticals | D: Filing D
Phio Pharmaceuticals | CORRESP: CORRESP
Phio Pharmaceuticals | UPLOAD: Others
Phio Pharmaceuticals | SCHEDULE 13G: Others
Phio Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
Phio Pharmaceuticals | SCHEDULE 13G: Others
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 424B5: Prospectus
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 424B5: Prospectus
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 424B5: Prospectus
Phio Pharmaceuticals | 8-K: Current report
Unlock the Full List